Is severe rejection an indication for retransplantation?
Kato
T
T
Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101-5809, USA.
Berho
M
M
Weppler
D
D
Ruiz
P
P
Pinna
A D
AD
Khan
F A
FA
Nery
J R
JR
Tzakis
A G
AG
D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007422:Intestines / Q000473:pathology / Q000637:transplantation*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology* / Q000401:mortality / Q000473:pathology*; D014781:Viscera / Q000637:transplantation
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3